ABSTRACT
Introduction
Urinary lithiasis is a condition that has been recognized for centuries, and is the third most common cause of urinary tract disease. Its prevalence ranges from 2 to 20% in the population 1 , with a 40 to 50% recurrence rate within five years 2 . The resulting work absenteeism and increased costs to the health system due to treatment of recurrent episodes of renal colic has major economic impact 1 . The annual cost to the U.S. of urolithiasis, including medical costs and lost work days, is about US$ 2.1 billion 3 . It is estimated that preventing urolith recurrence could result in an average savings of $2,158 ± $500 per patient/year 4 .
Metabolic changes frequently occur in patients with urolithiasis 5 , and metabolic evaluation should be part of the treatment protocol to allow diagnosis, and specific treatment, of possible metabolic disorders. Both dietary changes and specific drug treatments are important in urolith recurrence 6, 7 . Certain nutrients may promote or inhibit urolith formation 8, 9 . Drinking more liquids influences lithogenesis by increasing urinary volume and decreasing the concentration of lithogenic components 10 .
There is evidence that changes in lifestyle, when combined with appropriate medication, reduce the complications and recurrence rate associated with urolithiasis 6 .
In this study we evaluate the influence of combined drug therapy and nutritional guidance on urolith recurrence.
Methods

This study was approved by the Research Ethics
Committee of the School of Medicine of Botucatu, UNESP (Protocol CEP 3331-2009) and all patients gave their informed consent. The medical records of 400 patients with urolithiasis were reviewed. Fifty-seven patients met the inclusion criteria (age ≥18 years, creatinine clearance ≥ 60 ml / min, minimum followup period of at least five years). Patients were considered to have had regular outpatient follow-up when they had three follow-up evaluations in the first year, two in the second year, and at least 
Clinical questionnaire
The patients completed a clinical questionnaire, which included questions about their age, sex, weight, height, and history of uroliths (year of disease onset and number of stones passed). Body Mass Index (BMI) was calculated using the formula described by Garrow 11 and classified according to the World Health Organization (WHO) guidelines 12 .
Metabolic investigation protocol
Metabolic investigation was conducted on initial presentation and during the follow-up period. Two non-consecutive 24h urine samples were collected in order to determine concentrations of calcium (Ca), phosphorus (P), uric acid (UA), sodium (Na), potassium (K), creatinine (Cr), magnesium (Mg), chlorine (Cl), citrate (Ci), oxalate (Ox), cystine, uric acid (UA), and fasting serum glucose.
Imaging evaluation
All patients underwent ultrasound and/or abdominal radiographs at initial presentation. During follow-up examinations, these tests were repeated as needed to assess stone recurrence.
Dietary recommendations
As an initial recommendation, all patients were advised to increase their fluid intake to an amount sufficient to result in a urine volume greater than or equal to 2 liters/day. All patients were also instructed to maintain a protein intake of 0.8 to 1 g/kg body weight/ day and an adequate calcium intake (800 to 1000 mg/ day) 8 . Salt restriction (less than 5 g/ day) was recommended if appropriate based on their 24h urine sodium excretion 9 .
During the five year follow-up after the initial intervention, all patients received individualized and specific nutritional guidance appropriate to their specific metabolic changes. 
Drug therapy
All patients received specific pharmacological treatment according to their individual metabolic alterations (Table 1) . During the five years of follow-up, drug treatments were individually modified to suit changes in metabolic profiles.
Statistical analysis
Data were analyzed using SPSS. The periods before and during the intervention were compared using exploratory inferential analysis. In the presence of Gaussian distribution the paired t test was used and, when the data were not normally distributed, the nonparametric Wilcoxon test was used. Differences were considered statistically significant when p<0.05.
Results
The patients had a mean age of 45. 
Evaluation of urolith recurrence
The pre-treatment urolith recurrence rate (Rp) was considered to be the average yearly number of uroliths eliminated The number of stones during the 5-year follow-up period decreased significantly relative to the pre-treatment period (Table 3) .
(28% (16/57) vs. 33% (16/49), respectively; p>0.05). Although all patients in this study were advised to increase their fluid intake, few complied with this recommendation. This demonstrates the difficulty of using only this increased fluid intake as a strategy for the prevention of urolithiasis.
There was a significant decrease in urolith recurrence, as well as in urinary calcium and uric acid concentrations, over the five years follow-up period. This suggests that our intervention decreased the excretion of these solutes, thus preventing urolith formation and recurrence. Parks and Coe 21 also reported a longterm reduction in urolith recurrence and urine calcium excretion in patients receiving dietary guidance and drug treatment. Other authors also found similar results in a controlled study 22 .
Preventing urolith recurrence may decrease the costs associated with urolithiasis and have an important economic impact. However, there are few studies similar to this one available in the literature. This suggests that there is a need for greater involvement of different professionals in the prevention of urolithiasis.
Conclusion
Individual dietary guidance combined with specific drug treatment significantly reduces long-term recurrence of uroliths. 
Discussion
Recent epidemiological studies have shown an increasing prevalence of urolithiasis in both sexes 13 . This increase has been greater in women than in men, resulting in a decrease in the male:female ratio (from 1.7:1 to 1.3:1) of affected patients. This change may be related to increased body weights and changes in lifestyle among women 13, 14 . In this study we observed a similar trend; the male:female ratio of the patients in this study was 1.3:1.
Many of the patients in this study were overweight and there was a positive relationship between BMI and urolith formation. Some authors 15, 16 have shown that being overweight or obese is a risk factor for urolithiasis. Weight gain may also be related to the formation of kidney stones 17 , and weight reduction can decrease the excretion of lithogenic salts in the urine 18 . In this study, significant weight gain was not observed during the follow-up period. The dietary guidance provided to the patients probably prevented weight gain during the 5-year follow-up, which may have contributed to the reduced urolith recurrence rate.
Identification and correction of the metabolic disorders that may cause urolithiasis is critical to preventing its recurrence 19 .
In our patients, diet change coupled with specific pharmacological treatments had an important influence on urolith recurrence. The relationship between sodium intake and increased urinary calcium excretion is well established 20 . In another study, dietary salt intake was significantly higher in patients with idiopathic hypercalciuria 9 .
We observed a direct relationship between urinary calcium and sodium in the pre-treatment period, demonstrating that salt intake is an important lithogenic factor.
Increasing fluid intake is an important first intervention in the general treatment of urolithiasis 1 . Controlled studies have
shown that increasing urine volume to 2 liters/day can reduce urolith recurrence 10 . In this study, there was no difference in the proportion of patients whose urine volume was greater than or equal to 2000 ml during the pre-and post-treatment periods
